A comparative trial of haloperidol and thioridazine: Management of chronic schizophrenia

Australian and New Zealand Journal of Psychiatry

Volumn 7, Issue 1, 1973, Pages 52-57

  Weston, M J ^a   Bentley, R ^b   Unwin, A ^b   Morris, M ^b   Harper, M A ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; THIORIDAZINE;

ADVERSE DRUG REACTION; MAJOR CLINICAL STUDY; PSYCHIATRY; SCHIZOPHRENIA; THERAPY;

ADULT; CHRONIC DISEASE; CLINICAL TRIALS; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; THIORIDAZINE;

EID: 0015788611     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048677309161477     Document Type: Article

References (17)

1. Cohler J., Grinspoon L., Shader R., Chatterjee S. (1966). Behavioural correlates of the guessing game. Archives of General Psychiatry, 15: 279.
2. Crane G. E. (1967). A review of the clinical literature on Haloperidol. International Journal of Psychiatry, 3: Supplement No. 1, 110.
3. Derogatis L. R., Bonatur R. R., Young K. S. (1968). The power of the IMPS in psychiatric drug research. Archives of General Psychiatry, 19: 689.
4. Divry P., Bobon J., Collard J. (1958). Le “R 1625” nouvelle therapeutique symptomatique de l'agitation psychomotrice. Acta Neurologica Belgia, 58: 878.
5. Felger H. L. (1966). Thioridazine (Melleril) in the geriatric patient. Diseases of the Nervous System, 27: 537.
6. Fleischl H. (1967). Effects of thioridazine on clinically regressed patients. Journal of the American Geriatrics Society, 15: 29.
7. Gerle B. Linford Rees, W. L., Janssen P. A. J. (1967). European experiences with haloperidol. International Journal of Psychiatry, 3: Supplement No. 1, 42.
8. Goldberg S. C., Klerman G. L., Cole J. O. (1965). Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment. British Journal of Psychiatry, 111: 120.
9. Herman E., Pleassure H. (1963). Clinical evaluation of thioridazine and chlorpromazine in chronic schizophrenics. Diseases of the Nervous System, 24: 54.
10. Kellam S. G., Goldberg S. C., Schooler N. R., Berman A., Shmeltzer J. L. (1967). Ward atmosphere and outcome of treatment of acute schizophrenia. Journal of Psychiatric Research, 5: 145.
11. Khakee A., Hess G. (1960). Melleril in the treatment of chronically disturbed patients; with special reference to reduced extrapyramidal complications. American Journal of Psychiatry, 116: 1029.
12. Klett C. J., Lasky J. J. (1960). A clinical trial of five phenothiazines using sequential analysis. Journal of Clinical and Experimental Psychopathology, 21: 89.
13. Lorr M., O'Connor J. P., Stafford J. W. (1960). The psychotic reaction profile (PRP). Journal of Clinical Psychology, 16: 241.
14. Lorr M., McNair D. M., Klett C. J., Laskey J. J. (1962). In-patient Multidimensional Psychiatric Scale (IMPS). Consult. Psychol. Press, Palo Alto, California.
15. Prasad L., Townley M. C. (1966). Haloperidol and thioridazine in treatment of chronic schizophrenics. Diseases of the Nervous System, 27: 722.
16. Prien R. F., Klett C. J. (1970). An appraisal of the long-term use of tranquilizing medication with hospitalised chronic schizophrenics — a review of the drug discontinuation literature. Pre-publication Report No. 85, Central Neuropsychiatric Research Laboratory, Perry Point, Maryland.
17. Simpson G. M., Angus J. W. S., Edwards J. G. (1967). A controlled study of haloperidol in chronic schizophrenics. Current Therapeutic Research, 9: 407.